Nerandomilast 1 mg - paediatric formulation: Clinical Trials

1 trial of Nerandomilast 1 mg - paediatric formulation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Nerandomilast 1 mg - paediatric formulation: new trials by email Literature Review of Nerandomilast 1 mg - paediatric formulation trials Research Report on Nerandomilast 1 mg - paediatric formulation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food
Nerandomilast 18 mg - adult formulation, Nerandomilast 1 mg - paediatric formulation - Healthy
Phase 1CompletedBoehringer Ingelheim152024-10-152026-01-08

Sponsors

Boehringer Ingelheim (1)

Countries

Germany (1)